A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung Disease

Protocol No
INF-AN2-EBO-301-MAC
Phase
II/III
Summary

This project is being done to learn about the efficacy and safety of Epetraborole.

Description
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL